IGC on XASE, Health Care, IGC Pharma, Inc., job postings
Measures activity, not value. Not investment advice.
Cash of only $413K against an $8.1M 12-month net loss, while the stock fell 46% in a year.
BadInstitutional holders fell to 29 from 36 the quarter before, down 19%
GoodRevenue grew 14% over 12 months to $1.3M
Written by AI from the data on this page, 22 Nov 2026. Not investment advice.
Profile and fundamentals
From its SEC filings, 12 months to 30 Sep 2026
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $328K, net loss $2.0M.
31 Dec 2021RevenueNet incomeNet losstallest bar $6.5M30 Sep 2026
See the numbers
Quarter to
Revenue
Net income
30 Sep 2026
$328K
-$2.0M
30 Jun 2026
$265K
-$2.9M
31 Mar 2026
$317K
-$2.4M
31 Dec 2025
$350K
-$726K
30 Sep 2025
$191K
-$1.8M
30 Jun 2025
$328K
-$1.6M
31 Mar 2025
$330K
-$1.2M
31 Dec 2024
$257K
-$1.8M
30 Sep 2024
$412K
-$1.7M
30 Jun 2024
$272K
-$2.4M
31 Mar 2024
$295K
-$2.9M
31 Dec 2023
$204K
-$5.6M
30 Sep 2023
$291K
-$2.5M
30 Jun 2023
$555K
-$2.1M
31 Mar 2023
$166K
-$4.0M
31 Dec 2022
$332K
-$2.2M
30 Sep 2022
$202K
-$2.4M
30 Jun 2022
$212K
-$2.8M
31 Mar 2022
$122K
-$6.5M
31 Dec 2021
$142K
-$2.4M
Fundamentals, 12 months to 30 Sep 2026
Measure
Latest
Year before
Peer median
RevenueiSales over the last 12 months reported.
$1.3M
$1.1M
Revenue growthiRevenue of the last 12 months compared with the 12 months before.
+14%
+11%
Net incomeiProfit after all costs and taxes over the last 12 months reported. Negative is a loss.
-$8.1M
-$6.4M
EPS (diluted)iEarnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split).
-$0.08
-$0.08
Gross marginiWhat is left of each dollar of sales after the direct cost of making the product or service.
16.5%
46.2%
73.2%
Operating marginiOperating income as a share of sales: profit from the business before interest and taxes.
-803%
-732%
-25.0%
Net marginiNet income as a share of sales: what the owners keep of each dollar sold.
-644%
-583%
-18.2%
Return on equityiNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money.
-111%
-58.8%
Free cash flowiCash from operations minus capital spending over the last 12 months: cash the business produced.
–
-$5.6M
CashiCash, cash equivalents and short-term investments on the latest balance sheet.
$413K
$1.1M
DebtiShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted.
–
$136K
Net debtiDebt minus cash. Negative means the company holds more cash than it owes (net cash).
–
-$994K
Debt to equityiDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative.
–
0.0
Book value per shareiShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding.
$0.06
P/EiPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss.
loss
19.3
P/SiPrice to sales: market cap divided by revenue of the last 12 months.
15.6
5.0
EV/SalesiEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months.
–
5.0
P/BiPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative.
3.0
2.0
Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.
Peers nearest by market cap, its own industry first
Insider Buy/Sell iShares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.
–
No data for this company
Institutional holders iThe number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.
-19%
29 13F filers vs 36
Institutional ownership iShares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.
5.4%
6.3M shares held by 13F filers (30 Sep 2026) of 116.7M outstanding (3 Nov 2026)
Short interest iShares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.
0.3%
396K shares sold short (30 Oct 2026) of 116.7M outstanding (3 Nov 2026)
Days to cover iShort interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.
1.0
396K shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it
Short interest change iHow the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.
-38%
636K shares sold short in the report before, 396K on 30 Oct 2026
Short sale volume iShare of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.
27%
27% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 41%
Open jobs iJob postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.
–
We do not track this company's careers site yet.
Open jobs change iHow the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.
–
We do not track this company's careers site yet.
Employees iTotal staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.
–
No headcount in its annual reports in our data.
Visa hiring (foreign workers) iApplications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.
–
No data for this company
Revenue growth iSales in the latest reported quarter compared with the same quarter a year earlier.
–
No data for this company
Capital spending iMoney spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.
–
No data for this company
Federal contracts iMoney the US government committed to the company in contracts and grants over the last 12 months.
–
No data for this company
Lobbying iWhat the company reported spending on federal lobbying over the last four quarters.
–
No data for this company
Layoff notices iWorkers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).
–
No data for this company
News (7d) iArticles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.
6
6 articles in the last 7 days; its usual week has 1 (the median of the 26 weeks before).
News vs usual iArticles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.
6.0×
6 articles in the last 7 days; its usual week has 1.
Price $0.17 on 20 Nov 2026, -46% over 12 months (12-month range $0.17 to $0.35)
Sharp change
8-K and other filings
Insider net buying (open market). Insiders bought a net $0 in the last 12 months (the 12 months before: $0).Revenue per quarter. Revenue $328K in the latest quarter, +72% on a year earlier.Capital spending per quarter. Capital spending $5K in the latest quarter, -38% on a year earlier.Institutional holders (13F filers). 29 13F filers reported holding it in the latest 13F quarter, -15% on a year earlier.
Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: h-1b/e-3 applications certified, federal obligations, lobbying spend, workers in warn layoff notices.
Quarter ended 31 Dec 2021: $142K, +31% on a year earlier; public on 11 Feb 2022
Quarter ended 31 Mar 2022: $122K, +51% on a year earlier; public on 24 Jun 2022
Quarter ended 30 Jun 2022: $212K, +175% on a year earlier; public on 6 Aug 2022
Quarter ended 30 Sep 2022: $202K, +261% on a year earlier; public on 2 Nov 2022
Quarter ended 31 Dec 2022: $332K, +134% on a year earlier; public on 15 Feb 2023
Quarter ended 31 Mar 2023: $166K, +36% on a year earlier; public on 8 Jul 2023
Quarter ended 30 Jun 2023: $555K, +162% on a year earlier; public on 11 Aug 2023
Quarter ended 30 Sep 2023: $291K, +44% on a year earlier; public on 10 Nov 2023
Quarter ended 31 Dec 2023: $204K, -39% on a year earlier; public on 15 Feb 2024
Quarter ended 31 Mar 2024: $295K, +78% on a year earlier; public on 25 Jun 2024
Quarter ended 30 Jun 2024: $272K, -51% on a year earlier; public on 8 Aug 2024
Quarter ended 30 Sep 2024: $412K, +42% on a year earlier; public on 13 Nov 2024
Quarter ended 31 Dec 2024: $257K, +26% on a year earlier; public on 15 Feb 2025
Quarter ended 31 Mar 2025: $330K, +12% on a year earlier; public on 16 May 2026
Quarter ended 30 Jun 2025: $328K, +21% on a year earlier; public on 15 Aug 2025
Quarter ended 30 Sep 2025: $191K, -54% on a year earlier; public on 15 Nov 2025
Quarter ended 31 Dec 2025: $350K, +36% on a year earlier; public on 19 Mar 2026
Quarter ended 31 Mar 2026: $317K, -3.9% on a year earlier; public on 16 May 2026
Quarter ended 30 Jun 2026: $265K, -19% on a year earlier; public on 15 Aug 2026
Quarter ended 30 Sep 2026: $328K, +72% on a year earlier; public on 7 Nov 2026
Capital spending per quarter
Quarter ended 31 Dec 2021: $27K, -82% on a year earlier; public on 11 Feb 2022
Quarter ended 31 Mar 2022: $55K, -38% on a year earlier; public on 24 Jun 2022
Quarter ended 30 Jun 2022: $127K, +37% on a year earlier; public on 6 Aug 2022
Quarter ended 30 Jun 2023: $20K, -84% on a year earlier; public on 11 Aug 2023
Quarter ended 30 Sep 2023: $35K; public on 13 Nov 2024
Quarter ended 31 Dec 2023: $68K; public on 15 Feb 2025
Quarter ended 31 Mar 2024: $15K; public on 25 Jun 2024
Quarter ended 30 Jun 2024: $38K, +90% on a year earlier; public on 8 Aug 2024
Quarter ended 30 Sep 2024: $29K, -17% on a year earlier; public on 13 Nov 2024
Quarter ended 31 Dec 2024: $27K, -60% on a year earlier; public on 15 Feb 2025
Quarter ended 31 Mar 2025: $18K, +20% on a year earlier; public on 16 May 2026
Quarter ended 30 Jun 2025: $8K, -79% on a year earlier; public on 15 Aug 2025
Quarter ended 30 Sep 2025: $29K, 0% on a year earlier; public on 7 Nov 2026
Quarter ended 31 Dec 2025: $12K, -56% on a year earlier; public on 19 Mar 2026
Quarter ended 31 Mar 2026: $1K, -94% on a year earlier; public on 16 May 2026
Quarter ended 30 Jun 2026: $5K, -38% on a year earlier; public on 15 Aug 2026
Institutional holders (13F filers)
31 Dec 2021 report: 27; public on 14 Feb 2022
31 Mar 2022 report: 26; public on 16 May 2022
30 Jun 2022 report: 27; public on 15 Aug 2022
30 Sep 2022 report: 24; public on 14 Nov 2022
31 Dec 2022 report: 22; public on 14 Feb 2023
31 Mar 2023 report: 21; public on 15 May 2023
30 Jun 2023 report: 21; public on 14 Aug 2023
30 Sep 2023 report: 24; public on 14 Nov 2023
31 Dec 2023 report: 23; public on 14 Feb 2024
31 Mar 2024 report: 23; public on 15 May 2024
30 Jun 2024 report: 21; public on 14 Aug 2024
30 Sep 2024 report: 22; public on 14 Nov 2024
31 Dec 2024 report: 30; public on 14 Feb 2025
31 Mar 2025 report: 25; public on 15 May 2025
30 Jun 2025 report: 26; public on 14 Aug 2025
30 Sep 2025 report: 34; public on 14 Nov 2025
31 Dec 2025 report: 29; public on 17 Feb 2026
31 Mar 2026 report: 35; public on 15 May 2026
30 Jun 2026 report: 36; public on 14 Aug 2026
30 Sep 2026 report: 29; public on 16 Nov 2026
What is unusual now
Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is insider open-market buying (USD, Form 4) at $200K (27 Sep 2024), higher than 100% of its own history.
had 3.5M shares sold short in the 15 Jul 2025 report, 3.1× the same report last year.
Same report last year: 1.1M; its normal report is 964K.
See the evidence
This period
3.5M (the 15 Jul 2025 report)
Normal report (median of 24 earlier)
964K
Typical spread (median absolute deviation)
183K
How far from its usual level
+9.2
Same report last year
1.1M
History used
2,755 days
the 15 Jul 2025 report24 earlier reportsnormal: 964K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 1.7M shares sold short in the 30 Sep 2024 report, 2.1× the same report last year.
Same report last year: 797K; its normal report is 950K.
See the evidence
This period
1.7M (the 30 Sep 2024 report)
Normal report (median of 24 earlier)
950K
Typical spread (median absolute deviation)
110K
How far from its usual level
+4.3
Same report last year
797K
History used
2,467 days
the 30 Sep 2024 report24 earlier reportsnormal: 950K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 1.2M shares sold short in the 28 Jun 2024 report, 1.4× the same report last year.
Same report last year: 862K; its normal report is 898K.
See the evidence
This period
1.2M (the 28 Jun 2024 report)
Normal report (median of 24 earlier)
898K
Typical spread (median absolute deviation)
54K
How far from its usual level
+3.8
Same report last year
862K
History used
2,373 days
the 28 Jun 2024 report24 earlier reportsnormal: 898K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 1.3M shares sold short in the 14 Jun 2024 report, 1.5× the same report last year.
Same report last year: 865K; its normal report is 883K.
See the evidence
This period
1.3M (the 14 Jun 2024 report)
Normal report (median of 24 earlier)
883K
Typical spread (median absolute deviation)
48K
How far from its usual level
+5.0
Same report last year
865K
History used
2,359 days
the 14 Jun 2024 report24 earlier reportsnormal: 883K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 1.4M shares sold short in the 31 May 2024 report, 1.5× the same report last year.
Same report last year: 914K; its normal report is 883K.
See the evidence
This period
1.4M (the 31 May 2024 report)
Normal report (median of 24 earlier)
883K
Typical spread (median absolute deviation)
46K
How far from its usual level
+5.5
Same report last year
914K
History used
2,345 days
the 31 May 2024 report24 earlier reportsnormal: 883K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 1.3M shares sold short in the 15 May 2024 report, 1.5× the same report last year.
Same report last year: 897K; its normal report is 883K.
See the evidence
This period
1.3M (the 15 May 2024 report)
Normal report (median of 24 earlier)
883K
Typical spread (median absolute deviation)
44K
How far from its usual level
+5.1
Same report last year
897K
History used
2,329 days
the 15 May 2024 report24 earlier reportsnormal: 883K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 1.2M shares sold short in the 30 Apr 2024 report, 1.1× the same report last year.
Same report last year: 1.1M; its normal report is 883K.
See the evidence
This period
1.2M (the 30 Apr 2024 report)
Normal report (median of 24 earlier)
883K
Typical spread (median absolute deviation)
44K
How far from its usual level
+3.7
Same report last year
1.1M
History used
2,314 days
the 30 Apr 2024 report24 earlier reportsnormal: 883K
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 3.1M shares sold short in the 15 Mar 2021 report, 1.6× the same report last year.
Same report last year: 2.0M; its normal report is 2.0M.
See the evidence
This period
3.1M (the 15 Mar 2021 report)
Normal report (median of 24 earlier)
2.0M
Typical spread (median absolute deviation)
106K
How far from its usual level
+5.9
Same report last year
2.0M
History used
1,172 days
the 15 Mar 2021 report24 earlier reportsnormal: 2.0M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 2.7M shares sold short in the 26 Feb 2021 report, 1.4× the same report last year.
Same report last year: 2.0M; its normal report is 2.0M.
See the evidence
This period
2.7M (the 26 Feb 2021 report)
Normal report (median of 24 earlier)
2.0M
Typical spread (median absolute deviation)
90K
How far from its usual level
+3.8
Same report last year
2.0M
History used
1,155 days
the 26 Feb 2021 report24 earlier reportsnormal: 2.0M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 4.3M shares sold short in the 14 Aug 2020 report, 4.1× the same report last year.
Same report last year: 1.1M; its normal report is 1.9M.
See the evidence
This period
4.3M (the 14 Aug 2020 report)
Normal report (median of 24 earlier)
1.9M
Typical spread (median absolute deviation)
59K
How far from its usual level
+12.3
Same report last year
1.1M
History used
959 days
the 14 Aug 2020 report24 earlier reportsnormal: 1.9M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Showing the newest 40 of 58 entries; narrow the window or the kind of data to see older ones.
Not listed: 120 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.
Identifiers and sources
How records are matched to this company, and what each source holds for it
Cik
0001326205
Ticker
IGC
Domain
igcinc.us
Hq location
MD|POTOMAC|20854 (1 unverified)
Name
Hamsa Biopharma India Pvt. Ltd, HH Processors, LLC (formerly Holi Hemp, LLC), IGCare, LLC, IGC Enterprises Limited (IGC-ENT) and 9 more
SEC Form 13F institutional holdings481 data points30 Jun 2013 to 30 Sep 2026
SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)147 records16 Feb 2016 to 6 Nov 2026
SEC XBRL company facts (revenue, capex, R&D, backlog...)1064 data points31 Mar 2010 to 3 Nov 2026
SEC Form 4 insider transactions15 records, 48 data points5 Dec 2017 to 27 Sep 2024
FINRA short interest (twice monthly)600 data points29 Dec 2017 to 30 Oct 2026
FINRA daily short sale volume (off-exchange)4018 data points1 Aug 2018 to 20 Nov 2026